Detection of a MspI restriction fragment length polymorphism for the human sex hormone-binding globulin (SHBG) gene

John R. B. Perry, Michael N. Weedon, Claudia Langenberg, Anne Jackson, Valeriya Lyssenko, Thomas Sparsø, Guðmar Þorleifsson, Harald Grallert, Luigi Ferrucci, Marcello Maggio, Giuseppe Paolisso, Mark Walker, Nicholette D. Palmer, Felicity Payne, Elizabeth Young, Christian Herder, Narisu Narisu, Mario A. Morken, Lori L. Bonnycastle, Katharine R. Owen, Beverley M. Shields, Beatrice Knight, Amanda J. Bennett, Christopher J. Groves,

Letter2012

Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone‐binding globulin levels in premenopausal women

Bernardine H. Stegeman, M. RAPS, Frans M. Helmerhorst, Hans L. Vos, Hubertus A.A.M. van Vliet, Frits R. Rosendaal, Astrid van Hylckama Vlieg

Journal of Thrombosis and Haemostasis

Detection of a MspI restriction fragment length polymorphism for the human sex hormone-binding globulin (SHBG) gene

Abstract

Discussion(0)

Related publications

EcoRI restriction fragment length polymorphism in human glycogen synthase gene

Nuclear-encoded subunits of human cytochrome c oxidase: SstI restriction fragment length polymorphism

Sex hormone-binding globulin: an adequate surrogate marker for venous thromboembolism in women using new hormonal contraceptives

Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes

Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone‐binding globulin levels in premenopausal women